SMART wound dressing technology that releases antibiotics only when harmful bacteria are detected has shown promising results, accelerating healing and limiting resistance in preclinical models, offering a targeted approach to managing infected wounds more effectively in early studies conducted recently.
Background And Clinical Need for Wound Dressing Innovation
Wound infections remain a major clinical challenge, with rising antimicrobial resistance undermining standard treatments. The need for advanced wound dressing solutions has intensified as β-lactamase-producing bacteria increasingly drive persistent infections. Traditional antibiotic delivery often exposes tissue to suboptimal drug levels, encouraging resistance and recurrence. Hydrogels have emerged as versatile platforms for localised therapy, enabling controlled drug release and improved healing environments. This study explores a responsive wound dressing designed to release antibiotics only when infection-specific enzymes are present.
Enzyme Responsive Design Shows Strong Results in Models
Researchers developed a hydrogel incorporating a cephalosporin-derived β-lactamase cleavable crosslinker that degrades in the presence of bacterial enzymes, triggering release of ciprofloxacin-loaded liposomes. In ex vivo and in vivo models of Pseudomonas aeruginosa wound infections, the system demonstrated selective activation. In a murine skin abrasion infection model, a single application achieved complete bacterial eradication and enhanced wound healing, outperforming a commercial silver-based hydrogel wound dressing. Notably, the material did not induce ciprofloxacin resistance in non-β-lactamase-producing bacteria.
Implications For Practice and Future Wound Dressing Development
These findings highlight the potential of enzyme-responsive wound dressing systems to deliver antibiotics precisely at infection sites, reducing unnecessary exposure and limiting resistance development. Such targeted delivery could improve clinical outcomes, particularly in chronic or difficult-to-treat wounds where bacterial burden fluctuates. If validated clinically, this approach may redefine infection management by aligning antimicrobial therapy with real-time bacterial activity, supporting more sustainable and effective wound care strategies. Further evaluation of safety profiles and long-term resistance patterns will be essential before widespread clinical adoption.
Reference
Abbasi A et al. Bacterial enzyme-responsive hydrogels for triggered delivery of antibiotics to infected wounds. Science Advances. 2026;12(12):eadz0786.
Featured image: Vancouver on Adobe Stock
